CD8A and cancer: The diversity of CD8+ TCR beta chain variable region (Vbeta) gene sequences in both the peripheral blood and prostates of cancer patients exhibited restricted TCR Vbeta gene usage in CD8+ prostate infiltrating lymphocytes and express high levels of the inhibitory receptor PD-1.